Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0, while the study record still displays a 403 error.SummaryDifference0.3%

- Check13 days agoChange DetectedA sitewide NIH banner announces updates to terminology during a transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check20 days agoChange DetectedThe site footer's revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected content with an error message. The page retains standard site chrome (navigation/footer), indicating restricted access to the record.SummaryDifference0.5%

- Check40 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study record content and indicating the page is not accessible at this URL.SummaryDifference18%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.